Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Capital/Financing Update 2020

Sep 11, 2020

3535_iss_2020-09-11_5e51fc49-f6b6-444e-ba09-97e425000c6d.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA - RESULT OF SUBSEQUENT OFFERING

AQUA BIO TECHNOLOGY ASA - RESULT OF SUBSEQUENT OFFERING

Reference is made to the stock exchange notice by Aqua Bio Technology ASA (the

"Company") on 25 August 2020 regarding, inter alia, a subsequent offering with

gross proceeds of up to NOK 2,526,000 through issuance of up to 505,200 new

shares at a subscription price of NOK 5 per share (the "Subsequent Offering").

The application period in the Subsequent Offering ended on 10 September at

16.30 CEST. At the end of the application period, the Company had received

applications corresponding to the maximum amount of shares that can be allocated

in the Subsequent Offering. The new shares will be subscribed both through

subscription rights and from investors who participated in the private

placements announced on 17 and 18 August 2020.

The Company`s board of directors (the "Board") has now allocated shares in the

Subsequent Offering, which implies that the Company will issue 505,200 new

shares related to the Subsequent Offering. Allocation letters, regarding the

number of shares allocated and the subscription amount to be paid, will be

distributed to the subscribers shortly.

For further information, please contact Espen Kvale, CEO, telephone

+47 9162 8092.

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users.  ABT's focus on commercialization and development of natural

ingredients and natural skin care products has been, and will continue to be, an

important part of the company's strategy going forward. Aqua Bio Technology is

listed on the Axess market of the Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.